Science and Research Content

Accelrys ties up with Thomson Reuters for Cortellis for Informatics content -

Accelrys, Inc., a US-based scientific enterprise R&D software and services company, has announced a strategic content sourcing collaboration with the Intellectual Property & Science division of Thomson Reuters. The agreement will deliver relevant, current and expertly curated life sciences content from Thomson Reuters' Cortellis for Informatics via the scientifically aware Accelrys Enterprise Platform and related Accelrys software offerings including Pipeline Pilot, Symyx Notebook by Accelrys and Isentris. This in turn is projected to accelerate innovation, speed time-to-market and improve the competitiveness of pharmaceutical and biotech organisations.

The Accelrys Enterprise Platform incorporates cheminformatics applications and tools that meet the end-to-end needs of scientists to access, manage, analyse, report and share scientific information in a unified environment. This is expected to ensure consistency, accuracy and completeness of the chemistry and associated data being represented. Such a strong chemistry foundation is projected to establish Accelrys as the premier chemistry provider for Thomson Reuters' publishing and web operations.

The Accelrys Enterprise Platform claims to be the first scientifically aware, service-oriented architecture that enables the integration and deployment of broad scientific solutions across multiple domains in the lab-to-plant process. Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics in biopharmaceutical R&D.

The Accelrys Partner Program enables industry collaborators to combine their own products and services with Accelrys technologies on a single, scientifically aware platform. It is expected that this will reduce costs, enhance organisational efficiency, optimise IT infrastructure and improve innovation lifecycle management in new scientific areas. Beta testers at top-30 pharmaceutical companies are currently assessing the new Thomson Reuters Component Collection on the Accelrys Enterprise Platform. When beta testing is complete, this new data sourcing solution from Accelrys and Thomson Reuters will be generally available to organisations wishing to derive full value from Thomson Reuters Cortellis content.

Click here to read the original press release.

STORY TOOLS

  • |
  • |

sponsor links

For banner adsĀ click here